11/07/2025 16:00
Takeda Presents New Data Showing Mezagitamab (TAK-079) Sustained Effect on Kidney Function 18 Months After Treatment in Primary IgA Nephropathy
Takeda (TSE:4502/NYSE:TAK) today announced new interim data from the Phase 1b, open-label, proof-of-concept study of subcutaneous mezagitamab (TAK-079), an anti-CD38 monoclonal antibody with disease-modifying potential, in primary immunoglobulin A (IgA) nephropathy. Data from the study showed that kidney function (eGFR) remained stable in patients with IgA nephropathy through Week 96 – up to 18 months after the last mezagitamab dose.1 The results were presented at the American Society of Nephro...
12/10/2025 02:50
Biocytogen Completes STAR Market IPO, Becoming the First “H+A” Global Drug Innovator
Biocytogen (Beijing) Pharmaceutical Technology Co., Ltd. (“Biocytogen,” SSE: 688796; HKEX: 02315), a global biotechnology company advancing innovative drug discovery, today announced its successful listing on the Shanghai Stock Exchange STAR Market. This follows the Company’s listing on the Hong Kong Stock Exchange in September 2022 and marks a significant milestone in establishing Biocytogen as the first “H+A” dual-listed global drug innovator, reinforcing its mission to become the global head...
AFP photographer Christina Assi carries the Olympic Flame in honour of journalists killed on duty
AFP photographer Christina Assi, who was severely injured on assignment last October in Lebanon, will carry the Olympic Flame on Sunday, 21 July, in Vincennes, France, "to pay tribute to those who have fallen" while doing their job as journalists, she explained.
Christina Assi, 29, was struck by a tank shell on October 13, 2023 while reporting on cross-border clashes between the Israeli army and armed groups in southern Lebanon, alongside six other colleagues.
Anglais
AFP journalists among media honoured at Doha Forum
AFP journalists Christina Assi and Dylan Collins were among six media personnel honoured at the Doha Forum for political dialogue on Saturday for their sacrifices reporting from conflict zones.
AFP appoints first diversity editor
Lopez was the author of a report on diversity in the Agency’s coverage that she submitted to the global news management in May 2022.
Anglais
12/10/2025 03:29
Omdia: India’s PC Market Records Strongest-Ever Q3 2025 as Consumer Demand Surges
The latest research from Omdia reveals that India’s PC market (excluding tablets) posted its strongest quarterly performance on record, with shipments reaching 4.9 million units in Q3 2025, up 13% year on year. Notebook volumes climbed to 4.0 million units, rising 12% as vendors accelerated shipments ahead of the festive season and maintained stable fulfilment for commercial clients. Desktop shipments increased 18% to 920K units. India’s tablet market, however, contracted 19% year on year to 1....
12/10/2025 04:00
NayaPay Launches Global QR Payments for Pakistanis via Alipay+
NayaPay, one of Pakistan’s fastest growing fintech platforms, has launched global QR payments in collaboration with Alipay+, Ant International’s global wallet gateway. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251209591389/en/ The partnership enables millions of NayaPay users to scan-and-pay at Alipay+ merchants initially across more than 50 countries, connecting Pakistani consumers to an extensive global ecosystem spanning reta...
12/10/2025 06:01
Polpharma Biologics and Libbs Farmacêutica Sign Licensing Agreement for a Biosimilar for Autoimmune Diseases
Polpharma Biologics, a leading biopharmaceutical company specializing in the development and manufacturing of biosimilars, is thrilled to announce the signing of a landmark licensing agreement with the Brazilian company Libbs Farmacêutica! Through this strategic partnership, Libbs Farmacêutica will gain exclusive rights to commercialize a cutting-edge biosimilar for autoimmune diseases in the rapidly growing Brazilian market. Polpharma Biologics retains full responsibility for the development ...